Physician profile
Thomas A Keller
NPI 1972523918
$28,005.85
in general payments reported to CMS, 2019-2025
25 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $974 · 2020: $447 · 2021: $1,862 · 2022: $711 · 2023: $451 · 2024: $12K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $1,432 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,500.00 |
| Food and Beverage | $1,431.86 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,997.88 | 2019-2025 | Watchman, Watchman Access System, Watchman Flx |
| Abbott Laboratories | $1,736.69 | 2019-2025 | Portico, Cardiomems, Jot Dx |
| Astrazeneca Pharmaceuticals LP | $771.38 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $555.71 | 2019-2025 | |
| Edwards Lifesciences Corporation | $348.49 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $243.28 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $240.45 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $181.73 | 2020-2023 | Uptravi, Opsumit |
| Pfizer INC. | $138.62 | 2019-2025 | |
| Cardiva Medical, INC. | $117.50 | 2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $94.70 | 2021-2024 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $91.94 | 2022-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.78 | 2019-2024 | Jardiance |
| Abiomed | $71.05 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.01 | 2019-2024 | Lifevest |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $54.76 | 2019-2025 | Repatha |
| Cardiovascular Systems INC. | $43.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.42 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $28.60 | 2019 | |
| Shockwave Medical, INC | $21.55 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $18.82 | 2019 | |
| Daiichi Sankyo INC. | $17.98 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.53 | 2023 | Onpattro |
| Livanova USA, INC. | $14.39 | 2022 | |
| Cardinal Health 200 LLC | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.